Change in Ambulatory 
Significant reductions in 24‐hour, daytime, and nighttime SBP and DBP from baseline to week 8 were seen during treatment with sacubitril/valsartan 200 and 400 mg/d and olmesartan 20 mg/d in both the dipper and nondipper groups (Figure 